Dr. Farah Husein, Director of Science & Methods at Canada’s Drug Agency, introduces CDA-AMC’s role as a pan-Canadian health organization dedicated to improving coordination, alignment, and value in the drug and health technology system. The presentation outlines the agency’s expanded mandate following the 2023 government announcement, including three strategic pillars—Appropriate Use, Data & Analytics, and System Coordination—and time-limited projects under the new Pharmacare Act, such as developing a bulk purchasing strategy and essential medicines list.

Dr. Husein highlights key initiatives to promote appropriate prescribing, strengthen pan-Canadian data infrastructure, and enhance system integration, as well as innovative approaches to reimbursement and formulary management. The central message: CDA-AMC is building a more connected, data-driven, and sustainable pharmaceutical system to improve care for all Canadians.

View the presentation slides here:
Farah Husein CDA Presentation Slides